Yann Nadjar

1.4k total citations
37 papers, 551 citations indexed

About

Yann Nadjar is a scholar working on Physiology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Yann Nadjar has authored 37 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 12 papers in Molecular Biology and 11 papers in Clinical Biochemistry. Recurrent topics in Yann Nadjar's work include Lysosomal Storage Disorders Research (13 papers), Metabolism and Genetic Disorders (11 papers) and Mitochondrial Function and Pathology (6 papers). Yann Nadjar is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Metabolism and Genetic Disorders (11 papers) and Mitochondrial Function and Pathology (6 papers). Yann Nadjar collaborates with scholars based in France, United States and United Kingdom. Yann Nadjar's co-authors include Philippe Corcia, Vincent Meininger, Gordon Gilbert, François Salachas, Marion Masingue, Gilbert Bensimon, Foudil Lamari, Laurence Piéroni, Stéphane Epelbaum and Xavier Ayrignac and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Yann Nadjar

33 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yann Nadjar France 16 243 176 124 84 77 37 551
Foudil Lamari France 14 227 0.9× 257 1.5× 109 0.9× 78 0.9× 95 1.2× 28 582
E. Pennisi Italy 16 174 0.7× 308 1.8× 156 1.3× 32 0.4× 83 1.1× 41 667
Bernhard Weschke Germany 13 164 0.7× 547 3.1× 96 0.8× 71 0.8× 298 3.9× 23 985
Annette Bley Germany 14 349 1.4× 500 2.8× 47 0.4× 97 1.2× 115 1.5× 29 816
Kaja Kristine Selmer Norway 22 337 1.4× 342 1.9× 79 0.6× 59 0.7× 236 3.1× 65 1.1k
Mauro Scarpelli Italy 17 179 0.7× 535 3.0× 94 0.8× 62 0.7× 312 4.1× 34 796
Krystyna Mitosek‐Szewczyk Poland 13 112 0.5× 138 0.8× 100 0.8× 76 0.9× 23 0.3× 35 630
Eduardo Gutiérrez‐Rivas Spain 14 136 0.6× 233 1.3× 142 1.1× 20 0.2× 51 0.7× 25 620
David Bargiela United Kingdom 17 94 0.4× 412 2.3× 62 0.5× 49 0.6× 59 0.8× 30 855
Andrea J. Arreguin United States 8 124 0.5× 246 1.4× 138 1.1× 104 1.2× 38 0.5× 10 485

Countries citing papers authored by Yann Nadjar

Since Specialization
Citations

This map shows the geographic impact of Yann Nadjar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yann Nadjar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yann Nadjar more than expected).

Fields of papers citing papers by Yann Nadjar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yann Nadjar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yann Nadjar. The network helps show where Yann Nadjar may publish in the future.

Co-authorship network of co-authors of Yann Nadjar

This figure shows the co-authorship network connecting the top 25 collaborators of Yann Nadjar. A scholar is included among the top collaborators of Yann Nadjar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yann Nadjar. Yann Nadjar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mauhin, Wladimir, Javier I. Ottaviani, Olivier Lidove, et al.. (2024). Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry. Journal of Clinical Laboratory Analysis. 39(1). e25131–e25131.
2.
Uguen, Kévin, Sylvia Redon, Karen Rouault, et al.. (2024). An unusual diagnosis of alpha‐mannosidosis with ocular anomalies: Behind the scenes of a hidden copy number variation. American Journal of Medical Genetics Part A. 194(5). e63532–e63532.
3.
Mansour‐Hendili, Lamisse, Cyril Gitiaux, Céline Latouche, et al.. (2024). Recurrent “outsider” intronic variation in the SLC5A6 gene causes severe mixed axonal and demyelinating neuropathy, cyclic vomiting and optic atrophy in 3 families from Maghreb. Frontiers in Genetics. 15. 1352006–1352006. 1 indexed citations
4.
Shor, Natalia, Nicolas Villain, Maria del Mar Amador, et al.. (2024). Cognitive impairment in children and adults with cerebrotendinous xanthomatosis: A French cohort study. Journal of Inherited Metabolic Disease. 47(5). 1069–1079. 1 indexed citations
6.
Nadjar, Yann, Pierre Lévy, Vi‐Huong Nguyen‐Michel, et al.. (2022). Prognostic value of electroencephalographic paroxysms in post-anoxic coma: A new regularity EEG-based score. Neurophysiologie Clinique. 52(3). 223–231. 3 indexed citations
7.
Fernández‐Eulate, Gorka, Jean‐François Benoist, Foudil Lamari, et al.. (2022). Diagnostic approach in adult-onset neurometabolic diseases. Journal of Neurology Neurosurgery & Psychiatry. 93(4). 413–421. 13 indexed citations
8.
Fernández‐Eulate, Gorka, P. Dureau, Anaïs Brassier, et al.. (2022). Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts. Orphanet Journal of Rare Diseases. 17(1). 434–434. 2 indexed citations
9.
Tebani, Abdellah, Wladimir Mauhin, Lénaïg Abily-Donval, et al.. (2020). A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease. Journal of Clinical Medicine. 9(5). 1325–1325. 32 indexed citations
10.
Masingue, Marion, Timothée Lenglet, Cyril Goizet, et al.. (2020). Natural History of Adult Patients with GM2 Gangliosidosis. Annals of Neurology. 87(4). 609–617. 41 indexed citations
11.
Patterson, Marc C., William S. Garver, Jackie Imrie, et al.. (2020). Long‐term survival outcomes of patients with Niemann‐Pick disease type C receiving miglustat treatment: A large retrospective observational study. Journal of Inherited Metabolic Disease. 43(5). 1060–1069. 42 indexed citations
12.
Benoit, Charline, Guido Ahle, Cécile Cauquil, et al.. (2020). Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies. Journal of Neurology Neurosurgery & Psychiatry. 92(1). 27–35. 15 indexed citations
13.
Bauer, Peter, Thomas Klopstock, Yann Nadjar, et al.. (2019). Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C?. Orphanet Journal of Rare Diseases. 14(1). 20–20. 11 indexed citations
14.
Chaussenot, Annabelle, Gérard Besson, Foudil Lamari, et al.. (2019). Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults. Journal of Neurology. 266(8). 2043–2050. 30 indexed citations
15.
Masingue, Marion, Jean‐François Benoist, Emmanuel Roze, et al.. (2018). Cerebral folate deficiency in adults: A heterogeneous potentially treatable condition. Journal of the Neurological Sciences. 396. 112–118. 10 indexed citations
16.
Epelbaum, Stéphane, et al.. (2017). Cognitive impairment profile in adult patients with Niemann pick type C disease. Orphanet Journal of Rare Diseases. 12(1). 166–166. 25 indexed citations
17.
Masingue, Marion, Isaac Adanyeguh, Yann Nadjar, et al.. (2017). Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment. Orphanet Journal of Rare Diseases. 12(1). 22–22. 21 indexed citations
18.
Nadjar, Yann, Gordon Gilbert, Philippe Corcia, et al.. (2012). Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis. PLoS ONE. 7(9). e45034–e45034. 68 indexed citations
19.
Blasco, Hélène, Patrick Vourc’h, Yann Nadjar, et al.. (2011). Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 303(1-2). 124–127. 28 indexed citations
20.
Nadjar, Yann, et al.. (2011). Injection of interferon-beta in the morning decreases flu-like syndrome in many patients with multiple sclerosis. Clinical Neurology and Neurosurgery. 113(4). 316–322. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026